 The Supreme Court has rejected a nationwide opioid settlement with OxyContin maker Purdue Pharma that would have shielded its owners from civil lawsuits over the opioid toll. The justices voted 5-4 in rejecting a deal that would have let Purdue Pharma emerge from bankruptcy as a different entity with its profits used for treatment and prevention.